EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieKlinische Studie (Phase II)Open Access · CC BY-NC-ND 4.0

Effect of Intravenous Iron Dextran on Kidney Outcomes in Acute Kidney Injury with Iron Deficiency

Jonathan S Chávez-Iñiguez iD, Miguel Ibarra-Estrada iD, Edgar Joel Carmona-Morales iD, Ana Ron-Magaña, Rolando Claure-Del Granado iD, Juan Carlos Velez iD, Gael Chávez-Alonso iD, Carlos E Orozco-Chan iD, Estefania Villalvazo-Maciel, Tania M Anaya-Arce, Gonzálo Rodríguez-García iD, Guillermo Navarro-Blackaller iD und 6 weitere

Kidney360 · 2026

DOI: 10.34067/kid.0000001136 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Kidney360, 2026. Verfasst von Jonathan S Chávez-Iñiguez und 17 weiteren Autor:innen. Beteiligte Einrichtung: Nephrology Service, Hospital Civil de Guadalajara Fray Antonio Alcalde, Guadalajara, Mexico. Hauptthemen laut MEDLINE: Acute Kidney Injury, Iron-Dextran Complex, Anemia, Iron-Deficiency. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: CSRD VA, Secretaria Nacional de Ciencia y Tecnología.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Key Points Iron deficiency is common in patients with AKI. It is unknown whether treating iron deficiency in AKI with intravenous iron reduces the risk of major adverse kidney events. In AKI and iron deficiency, intravenous iron did not reduce the risk of major adverse kidney events at 90 days.

Background

During AKI, iron deficiency may contribute to worse clinical outcome by interfering cellular repair. Correcting iron deficiency with intravenous (IV) dextran iron may reduce the risk of major adverse kidney events (MAKEs). We aimed to assess whether IV iron was more efficacious than conventional management for reducing MAKE in patients with AKI–iron deficiency.

Methods

In a phase 2 randomized controlled trial, from July 2022 to September 2024, patients with AKI and iron deficiency (iron levels

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acute Kidney InjuryIron-Dextran ComplexAnemia, Iron-DeficiencyHumansFemaleMaleMiddle AgedAgedInfusions, IntravenousTreatment Outcome

Stichwörter der Autor:innen

AKIKRTacute kidney failureacute renal failureanemiaintravenousmortality

Substanzen

Iron-Dextran Complex

Autor:innen und Institutionen

  • Nephrology Service, Hospital Civil de Guadalajara Fray Antonio Alcalde, Guadalajara, Mexico.
  • University of Guadalajara Health Sciences Center, Guadalajara, Mexico.
  • Intensive Care Unit, Hospital Civil de Guadalajara Fray Antonio Alcalde, Guadalajara, Mexico.
  • Hematology Service, Hospital Civil de Guadalajara Fray Antonio Alcalde, Guadalajara, Mexico.
  • Division of Nephrology, Hospital Obrero No 2 - Caja Nacional de Salud, Cochabamba, Bolivia.
  • IIBISMED, Facultad de Medicina, Universidad Mayor de San Simón, Cochabamba, Bolivia.

ORCID-Profile: Jonathan S Chávez-Iñiguez, Miguel Ibarra-Estrada, Edgar Joel Carmona-Morales, Rolando Claure-Del Granado, Juan Carlos Velez, Gael Chávez-Alonso, Carlos E Orozco-Chan, Gonzálo Rodríguez-García, Guillermo Navarro-Blackaller, Ramón Medina-González, Alejandro Martínez Gallardo-González, Luz Alcantar-Vallin, Juan A Gómez-Fregoso, Gabriela J Abundis-Mora, Guillermo García-García

Förderung

  • CSRD VA
  • Secretaria Nacional de Ciencia y Tecnología

Zitieren

APA

Chávez-Iñiguez, J. S., Ibarra-Estrada, M., Carmona-Morales, E. J., Ron-Magaña, A., Claure-Del Granado, R., Velez, J. C., Chávez-Alonso, G., Orozco-Chan, C. E., Villalvazo-Maciel, E., Anaya-Arce, T. M., Rodríguez-García, G., Navarro-Blackaller, G., Medina-González, R., Gallardo-González, A. M., Alcantar-Vallin, L., Gómez-Fregoso, J. A., Abundis-Mora, G. J., & García-García, G. (2026). Effect of Intravenous Iron Dextran on Kidney Outcomes in Acute Kidney Injury with Iron Deficiency. Kidney360. https://doi.org/10.34067/kid.0000001136

Vancouver

Chávez-Iñiguez JS, Ibarra-Estrada M, Carmona-Morales EJ, Ron-Magaña A, Claure-Del Granado R, Velez JC, et al. Effect of Intravenous Iron Dextran on Kidney Outcomes in Acute Kidney Injury with Iron Deficiency. Kidney360. 2026. doi:10.34067/kid.0000001136

BibTeX
@article{ChvezIiguez2026,
  author = {Chávez-Iñiguez, Jonathan S and Ibarra-Estrada, Miguel and Carmona-Morales, Edgar Joel and Ron-Magaña, Ana and Claure-Del Granado, Rolando and Velez, Juan Carlos and Chávez-Alonso, Gael and Orozco-Chan, Carlos E and Villalvazo-Maciel, Estefania and Anaya-Arce, Tania M and Rodríguez-García, Gonzálo and Navarro-Blackaller, Guillermo and Medina-González, Ramón and Gallardo-González, Alejandro Martínez and Alcantar-Vallin, Luz and Gómez-Fregoso, Juan A and Abundis-Mora, Gabriela J and García-García, Guillermo},
  title = {Effect of Intravenous Iron Dextran on Kidney Outcomes in Acute Kidney Injury with Iron Deficiency},
  journal = {Kidney360},
  year = {2026},
  doi = {10.34067/kid.0000001136}
}
Kostenlos starten →